Egyptian International Pharmaceuticals Industries Co SAE operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Egyptian International Pharmaceuticals Industries Co SAE with three other
pharmaceutical manufacturers in Middle East:
sales of 1.99 billion Egyptian Pounds [US$126.76 million]
of which 68%
was Medical Sector),
Dar Al Dawa Development and Investment Company PSC
(53.15 million Jordanian Dinars [US$74.97 million]
of which 77%
was Medicine), and
Alexandria Company for Pharmaceuticals and Chemical Industries SAE
(1.02 billion Egyptian Pounds [US$65.19 million]
During the second
quarter of 2021, sales at Egyptian International Pharmaceuticals Industries Co SAE totalled
770.89 million Egyptian Pounds.
an increase of 12.3%
from the 686.18 million Egyptian Pounds in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 1.58 billion Egyptian Pounds, which is
than through the first two quarters of 2020.
During the year ended December of 2020, sales at
Egyptian International Pharmaceuticals Industries Co SAE were 2.91 billion Egyptian Pounds (US$185.09 million).
decrease of 14.7%
versus 2019, when the company's sales were 3.41 billion Egyptian Pounds.